Table 2 Characteristics of the 60 compensated cirrhosis cohort divided into 28 stable control patients followed longitudinally in this paper, and those non-returner patients excluded as they either failed to return for repeat assessments or developed a clinical outcome. Also shown is the 10 healthy volunteer group followed longitudinally

N

28

32

10

Gender

17 male (61%)

18 male (56%)

6 male (60%)

Age (years)

59 (8)

59 (13)

63 (4)

Aetiology

29% NALFD/18% ALD/25% HCV/28% other

40% NAFLD/37% ALD/15% HCV/7% other

N/A

BMI (kg/m²)

27.5 (5.6)

28.5 (4.9)

26 (3.0)

MELD

7.5 (1.6)

6.9 (1.8)

N/A

UKELD

43.1 (2.9)

43.5 (2.3)

N/A

APRI

0.71 (0.61)

0.71 (1.2)

N/A

FIB4

2.5 (1.8)

2.9 (1.9)

N/A

ELF score

10.2 (1.2)

11.5 (1.9)

8.9 (0.8)

Fibroscan® LSM (kPa)

18 (17)

23 (21)

N/A